Related Experiment Videos
[Hemotherapy in malignant hematologic diseases]
Schweizerische Medizinische Wochenschrift
|June 14, 1975
For the majority of patients with malignant blood diseases the ideal transfusion products are blood components instead of whole blood. The therapeutic use of packed red cells, platelets, leukocytes and albumin is briefly discussed.
For the majority of patients with malignant blood diseases the ideal transfusion products are blood components instead of whole blood. The therapeutic use of packed red cells, platelets, leukocytes and albumin is briefly discussed.